Critical Summary The article by Malkin et al. presents the results of a phase 1, double-blind, randomized clinical trial evaluating the safety and immunogenicity of the rVSVΔG-LASV-GPC vaccine, a recombinant vesicular...
References Chaudhary M, Cutland CL, Bonet M, et al. Burden of Lassa fever disease in pregnant women and children and options for prevention. Vaccine. 2025;43(Pt 1):126479. doi:10.1016/j.vaccine.2024.126479 Summary Lassa...
Researchers at the University of Liverpool and the University of Oxford have for the first time been able to estimate the current burden of Lassa fever, project the impacts of a Lassa fever vaccination programme and...
New analysis by scientists at Scripps Research and University of Brussels finds that climate change and other factors could soon make deadly Lassa fever a much bigger public health problem in Africa In the study, which...